TUXUMDONLAR POLIKISTOZI SINDROMI BO'LGAN BEMORLARDA LETROZOL BILAN SINAMA NATIJALARINI BAHOLASH

##article.authors##

  • S.S. Sadirova
  • S.U. Irgasheva

##article.subject##:

TPKS, fenotiplar, tuxumdon aromataza faolligi, sitoxrom P-450

##article.abstract##

Ushbu maqolada O'zbekistonda tuxumdonlar polikistozi sindromi bo'lgan reproduktiv yoshdagi ayollarda letrozol bilan sinama natijalarini baholash tahlili keltirilgan. Tadqiqot maqsadi: TPKS turli fenotiplari bilan kasallangan reproduktiv yoshdagi ayollarda tuxumdonlar funktsional faolligini aromataza P450 ingibitori letrozol yordamida baholash. Materiallar va usullar : Tadqiqot davomida 41 ta TPKS ning turli fenotiplari bilan kasallangan 19 yoshdan 35 yoshgacha bulgan reproduktiv yoshdagi ayollar tekshirildi. Kasallarga TPKS va uning fenotiplarining tugri tashxisi Rotterdamdagi konsensus (2003 y) kursatmalariga binoan quyildi. Kasallarda tuxumdonlarning funktsional faolligini aniqlash va urganish maqsadida  funktsional sinama utkazildi. Sinama  aromataza ingibitori letrozol yordamida olib borildi. Tuxumdonlarning funktsional faolligini, ya’ni follikullalar aromataza faolligini aniqlashda quyidagi formuladan foydalanildi. Follikullarning aromataza faolligini baholash uchun formula bo'yicha quyidagi koeffitsient ishlatildi: K = DE2/AMG, bu erda K - antral tuxumdon follikullarining aromataza faolligi koeffitsienti; DE2 - letrozolni qabul qilgandan keyin 48 soat o'tgach, qon zardobida nmol / l ga estradiolning pasayishi; AMG - ng / ml da anti-Myuller gormonining qondagi miqdori  Natijalar va uning muhokamasi: Tadqiqot natijalarini tahlili shuni ko'rsatadiki,  TPKS bilan og'rigan bemorlarda follikullarning aromataza faolligida  xilma-xillik kuzatildi : bemorlarning 21,6 foizida u normal chegaralarda edi, bemorlarning 29,6 foizida ko'tarildi, bemorlarning 48,8 foizida pasaydi. Follikullarning aromataza faolligiga qarab, turli xil TPKS fenotiplari bo'lgan bemorlar uchta guruhga bo'lindi: past, o'zgarmagan va yuqori aromataza faolligi. Xulosa:Tadqiqot natijalari tuxumdonlar polikistoz sindromida sitoxrom p-450 aromataza fermentining turli xil faollik darajasini kursatdi. Tuxumdon aromatazasining nisbiy etishmovchiligi kasallikning fenotipiga qarab turli chastotalarda aniqlanishi mumkin

Библиографические ссылки

Erickson G. Follicle growth and development. Gynecol Obstet. 2001;5(12):2061-2071 V.K..

3 . S.U. Irgasheva, D.V. Gulammaxmudova , M.M. Aliyeva. Sravnitelьnaya otsenka klinicheskix pokazateley razlichnыx form polikistoza yaichnikov. Novosti dermatovenerologiya i reproduktivnoye zdorovьya, 2017 g, N4, s.59-60.

D.M.Lukayanova, Ye.P Xaщenko, Ye.V.Uvarova. Molekulyarno geneticheskiye aspektы formirovaniya fenotipov SPKYa u devochek podrostkov. Reproduktivnoye zdorovьe detey i podrostkov / 2015, №5 S. 46-53.

V.K. Lixachev, Prakticheskaya ginekologiya s neotlojnыmi sostoyaniyami, OOO “Meditsinskoye informatsionnoye agenstvo” 2013g. Str 280.

I. P. Nikolayenkov, V.V. Potin, M. A. Tarasova, M. I. Yarmolinskaya, N.N. Tkachenko, Ya. A. Samoylovich, Ye. M. Timofeyeva. Aktivnostь ovarialьnoy aromatazы u bolьnix sindromom polikistoznыx yaichnikov. Akusherstva i jenskixь bolьzney. 2014 № 1. S.10-15.

Ye.M. Timofeyeva, Ye.V. Misharina, I.P. Nikolayenkov, Ya.A. Samoylovich, N.N. Tkachenko. Metodicheskiye podxodы k opredeleniyu ovarialьnoy aromatazы pri sindrome polikistoznыx yaichnikov. // Akusherstva i jenskixь bolьzney. 2016 № 1 S. 54-61

S.V. YuRENEVA, k.m.n. L.M. ILЬINA. Sovremennыye rekomendatsii po lecheniyu sindroma polikistoznыx yaichnikov: preimuщestva oralьnыx kontratseptivov s antiandrogennыmi progestinami. Problemы reproduktsii, 2017, №4, S. 56-64.

The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(PCOS) // Hum. Reprod. 2004. Vol. 19, N 1. P. 41–47..

Djoxam A.E. i soavt. Sindrom polikistoznix yaichnikov. Lanset Diabet Endokrinol.2022.PMID35934017 obzor.

Lizneva D.,Suturina L., Walker W.,Brakta S., Gavrilova-Jordan L., Azziz R. Criteria, prevalence and phenotypes of polycystic ovary syndrome. Fertil.Steril.2016. 106(1); 6-15.

Osawa Y, Yoshida N, Fronckowiak , et al. Immuno¬affinity purification f aromatase cytochrome P 450 from human placental microsomes, metabolic switch¬ing from aromatization to 1- and 2-monohydroxylation, and recognition faromatase sozymes. Steroids. 1987; 50:11-28. : 10.1016/0039-128X(83)90058-2.

Загрузки

##submissions.published##

2023-09-22